Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Accelerate Diagnostics, Inc. (NASDAQ: AXDX).

Full DD Report for AXDX

You must become a subscriber to view this report.


Recent News from (NASDAQ: AXDX)

Accelerate Diagnostics' (AXDX) CEO Lawrence Mehren on Q1 2018 Results - Earnings Call Transcript
Accelerate Diagnostics, Inc. (AXDX) Q1 2018 Results Conference Call May 00, 2018 04:30 PM ET Executives Laura Pierson - IR Lawrence Mehren - President and CEO Steve Reichling - CFO, CAO and Secretary Analysts Tycho Peterson - JP Morgan Bill Quirk - Piper Jaffray Brian W...
Source: SeekingAlpha
Date: May, 09 2018 20:09
Accelerate Diagnostics misses by $0.05, misses on revenue
Accelerate Diagnostics (NASDAQ: AXDX ): Q1 EPS of -$0.37 misses by $0.05 . More news on: Accelerate Diagnostics, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: May, 09 2018 16:08
Accelerate Diagnostics reports Q1 2018 financial results
TUCSON, Ariz., May 09, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. today announced financial results for the quarter ending March 31, 2018.  The company generated revenue of $801,000, up 51% from the prior year, and reported signed agreements for 345 instruments. Contracts fo...
Source: GlobeNewswire
Date: May, 09 2018 16:03
Report: Developing Opportunities within US Ecology, Universal Health Realty Income Trust, Accelerate Diagnostics, Chesapeake Lodging Trust, Super Micro Computer, and Choice Hotels International - Future Expectations, Projections Moving into 2018
NEW YORK, May 04, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of US Ecology, Inc. (NASDAQ:ECOL), Universal Health Realty Income Trust (NYSE...
Source: GlobeNewswire
Date: May, 04 2018 07:35
Accelerate Diagnostics to Review First Quarter 2018 Results on May 9th
TUCSON, Ariz., April 30, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today it will host a conference call on Wednesday, May 9, 2018 to review its first quarter 2018 financial results and commercial progress. President and Chief Executive Officer, Lawrence Mehren, joine...
Source: GlobeNewswire
Date: April, 30 2018 10:42
Accelerate Diagnostics announces sizeable release of new data at ECCMID 2018
TUCSON, Ariz., April 21, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. today announced the sizeable release of new data presented by the company, its customers, and clinical experts during the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) 2018, loc...
Source: GlobeNewswire
Date: April, 21 2018 03:37
Accelerate Diagnostics prices $150M convertible debt offering
Accelerate Diagnostics (NASDAQ: AXDX ) prices its private offering of $150M of 2.50% convertible senior note due 2023 to institutional investors. Initial buyers will have the option to purchase up to an additional $30M of the notes. More news on: Accelerate Diagnostics, Inc., Healthcare ...
Source: SeekingAlpha
Date: March, 23 2018 07:04
Accelerate Diagnostics, Inc. Announces Pricing of $150 Million Convertible Notes Offering
TUCSON, Ariz., March 23, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (“Accelerate Diagnostics”) (NASDAQ:AXDX) today announced the pricing of $150.0 million aggregate principal amount of 2.50% convertible senior notes due 2023 (the “notes”) in a private ...
Source: GlobeNewswire
Date: March, 23 2018 02:15
Accelerate Diagnostics Inc. Announces $150 Million Convertible Notes Offering
TUCSON, Ariz., March 22, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (NASDAQ:AXDX) today announced its intention to offer, subject to market conditions and other factors, $150.0 million aggregate principal amount of convertible senior notes due 2023 (the “notes”) in ...
Source: GlobeNewswire
Date: March, 22 2018 07:08
Daily Insider Ratings Roundup For March 6, 2018: FOLD, RDUS, BW, AXDX, TMUS, GKOS, And BOMN
InsiderInsights' Daily Round Up articles rate the "significance" of the top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the significance of an insider transaction, however, and there are many more "Signifi...
Source: SeekingAlpha
Date: March, 07 2018 18:35

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-05-1721.7022.1522.2521.65383,301
2017-06-2028.2028.2528.6527.95149,561
2017-06-1927.9528.2528.4027.50231,542
2017-06-1626.9527.9028.081526.764295,327
2017-06-1526.3027.1527.2026.10262,652

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-08-1614,75720,99970.2748Short
2018-08-1519,79828,62369.1682Short
2018-08-1427,14644,00061.6955Short
2018-08-1330,78843,23271.2158Short
2018-08-1033,50838,86486.2186Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on AXDX.


About Accelerate Diagnostics, Inc. (NASDAQ: AXDX)

Logo for Accelerate Diagnostics, Inc. (NASDAQ: AXDX)

Not available

 

Contact Information

 

 

Current Management

  • Thomas V. Geimer / CEO, CFO, Secretary
  • David C. Howson / President

Current Share Structure

  • Market Cap: $1,115,327,180 - 05/14/2018
  • Issue and Outstanding: 55,766,359 - 02/23/2018

 


Recent Filings from (NASDAQ: AXDX)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 14 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 10 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 08 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 12 2018
Amendment to a SC 13D filing
Filing Type: SC 13D/AFiling Source: edgar
Filing Date: April, 12 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 28 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: March, 01 2018
Amendment to a SC 13D filing
Filing Type: SC 13D/AFiling Source: edgar
Filing Date: February, 20 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: February, 15 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: February, 14 2018

 

 


Daily Technical Chart for (NASDAQ: AXDX)

Daily Technical Chart for (NASDAQ: AXDX)


Stay tuned for daily updates and more on (NASDAQ: AXDX)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: AXDX)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in AXDX is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of AXDX and does not buy, sell, or trade any shares of AXDX. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/